Back to Authors

Hemnes, A.

A5021427879 | I200719446

Mayo Clinic

Vanderbilt University

Citations 4

Pulmonary Hypertension and Anastrozole (Phantom): A Randomized Clinical Trial

D106. HOT OFF THE PRESSES! LATE BREAKERS IN PULMONARY VASCULAR DISEASE | May 1, 2023 | Volume: No volume available | Issue: No issue available | Pages: A6727-A6727

10.1164/ajrccm-conference.2023.207.1_meetingabstracts.a6727

Medication Non-adherence and Health-related Outcomes in Patients With Pulmonary Arterial Hypertension: The Pulmonary Hypertension Association Registry (PHAR)

A26. PRECISION-BASED APPROACHES TO PULMONARY VASCULAR DISEASE | May 1, 2023 | Volume: No volume available | Issue: No issue available | Pages: A1186-A1186

10.1164/ajrccm-conference.2023.207.1_meetingabstracts.a1186

Role of Suppression of Tumorigenecity (ST2) in Pulmonary Vascular Complications of Liver Disease

D56. X MARKS THE SPOT: NEW BIOMARKERS IN PAH | August 26, 2019 | Volume: No volume available | Issue: No issue available | Pages: A6821-A6821

10.1164/ajrccm-conference.2019.199.1_meetingabstracts.a6821

Obesity and Quality of Life in Pulmonary Arterial Hypertension (PAH): The Pulmonary Hypertension Association Registry (PHAR)

A105. GLORY DAYS: THE LATEST CLINICAL RESEARCH IN PAH | August 26, 2019 | Volume: No volume available | Issue: No issue available | Pages: A2510-A2510

10.1164/ajrccm-conference.2019.199.1_meetingabstracts.a2510